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Abstract: Shiga toxin-producing Escherichia coli (STEC) serotype O157:H7 is one of the most important human pathogenic microorganisms, 
which can cause life-threatening infections. Xanthium strumarium L. is a plant with anti-bacterial activity against gram-negative and gram-po-
sitive bacteria. This study aims to demonstrate in vitro efficacy of the essential oil (EO) extracted from Xanthium strumarium L. against E. coli 
O157:H7. Using the agar test diffusion, the effect of Xanthium strumarium L. EO (5, 10, 15, 30, 60, and 120 mg/mL) was verified at each of 
the four different growth phases of E. coli O157:H7. Cell counts of viable cells and colony forming unit (CFU) were determined at regular time 
points using Breed’s method and colony counting method, respectively. No viable cell was detectable after the 1 hour-exposure to X. strumarium 
EO at 30, 60, and 120 mg/mL concentrations. No bacterial colony was formed after 1 h until the end of the incubation period at 24 h. At lower 
concentrations, the number of bacteria cells decreased and colonies could be observed only after incubation. At the exponential phase, the EO at 
15 mg/mL was only bacteriostatic, while from 30 mg/mL started to be bactericidal. X. strumarium EO antibacterial activity against Shiga toxin-
producing E. coli O157:H7 is dependent on EO concentration and physiological state of the microorganisms tested. The best inhibitory activity 
was achieved during the late exponential and the stationary phases. 
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Introduction
Escherichia coli is a Gram-negative bacteria, usually 
living in human and animal gut. Although, most of E. 
coli strains do not cause any diseases, the shiga toxin-
producing E. coli (STEC) can cause serious and life-
threatening infections in humans, including severe 
dysentery, hemorrhagic colitis, and hemolytic uremic 
syndrome. Children and elderly adults are at the highest 
risk of infection, which usually occurs by ingestion of 
contaminated food or water throughout oro-fecal trans-
mission (1). E. coli O157:H7 is the most common, but 
not the unique, entero-hemorrhagic serotype of STEC, 
harboring and expressing the genes for Shiga toxin type 
1 (Stx1) and 2 (Stx2). Shiga toxin acts against endothe-
lial cells and it is composed by two subunits: B subunit 
binds a component of the cell membrane to form a com-
plex, which is internalized, then the A subunit, an N-gly-
cosidase, inactivates the RNA of ribosomes, impairing 
protein biosynthesis and compromising cell survival.
Herbal medicine, ancient medical cure in human his-
tory, could be considered one of the former candidates 
of the modern pharmaceutical, currently contributing to 
treatment of certain diseases (2-6), though clinical evi-
dence of efficacy is still demanding in the majority of 
cases. Herbal medicine uses, among the other natural 
compounds, essential oils (EO), complex mixtures of 
lipophilic, volatile and aromatic plant secondary meta-
bolites (7, 8). Pre-clinical evidence exists supporting 
EO activities against a plethora of pathogens, related to 
clinically relevant diseases (9-14).
Xanthium strumarium L. (common name: cockle-
bur) is an annual plant belonging to the Asteraceae. Dif-
ferent parts of this plant have been proposed as remedies 
for treating a plethora of infectious diseases because of 
overwhelming activities including antiviral (15), antis-
taphylococcal (16), antileishmanial (17), antitrypanoso-
mal (18), antihelmintic (19), anti-inflammatory (20, 21) 
effects. Antiulcerogenic (22), diuretic (23), and hypo-
glycemic (24) activities further promoted this plant for 
potential use in the management of chronic diseases, 
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from peptic ulcers to diabetes or arterial hypertension. 
This study investigates the anti-shiga toxin activity 
of X. strumarium L. EO against E. coli O157:H7, using 
time kill assay in a batch culture.
Materials and Methods
Plant material
The Xanthium strumarium L. leaves were collected 
between August-September 2013 from area of Hamun 
Lake of Zabol, Sistan and Baluchestan Province, Iran. 
The plant was taxonomically identified at the Depart-
ment of Botany of Shahid Beheshti University of Medi-
cal Sciences, Tehran, Iran, where a voucher specimen 
was conserved.
Essential Oil extraction
Fresh leaves (1 kg) were detached from the stem 
and dried in the shade for 96 h. Then, they were chop-
ped and hydro-distilled for 3 h utilizing an all-glass 
Clevenger-type apparatus. The distillate was saturated 
with sodium chloride (NaCl) (Merck, Darmstadt, Ger-
many) and the X. strumarium L. EO was extracted with 
n-hexane (Merck) and dichloromethane (Merck). The 
EO obtained was dried over anhydrous sodium sulphate 
(Sigma-Aldrich, St. Louis, MO, USA) and stored at 4 
°C for future assays. Full chemical characterization of 
the X. strumarium L. EO is described in our previous 
work (13).
Bacterial strains and culture condition
Shiga toxin-producing E. coli O157:H7 (Gen-Bank 
accession number JX161807 and JX161808) was kept 
on nutrient agar at 4 ºC. Before usage, bacteria sub-
cultures were performed thrice on a fresh nutrient agar 
plate and incubated at 37 ºC overnight. Single colonies 
were transferred to 10 mL of nutrient broth, were grown 
overnight in this broth at 37 °C with shaking (180 rpm) 
and bacterial cell suspension were, then, homogenized 
with mixing. By preparing 10-fold serial dilutions of 
the suspension which each dilution (0.1 mL) was spread 
on the surface of nutrient agar plate, the total CFU/mL 
(log10 CFU/mL) were determined after 24 h incubation 
at 37 ºC (25-27).
Antibacterial activity
The agar diffusion method allowed determining the 
antibacterial activity of X. strumarium L. EO, as recom-
mended by Clinical and Laboratory Standards Institute 
(28). Briefly, 100 of the bacterial suspension were ino-
culated on the nutrient agar. The filter discs (Whatmann 
No. 1) were saturated with 20 μL of X. strumarium EO, 
then put on the agar plates which had been inoculated 
with 100 μL  E. coli O157:H7. The negative control 
was a filter disc without any sample and the positive 
reference was Chloramphenicol disc (30 μg/disc). The 
plates were 24 h incubated at 37 ºC. Finally, antibacte-
rial activity was determined by measuring the diameter 
of the growth inhibition zones (mm) compared to the 
control (29).
Standard growth curve determination of E. coli 
O157:H7
The growth curve was determined according to the 
Clinical and Laboratory Standards Institute (28). Briefly, 
0.5 mL of E. coli O157:H7 suspension was mixed with 
49.5 mL nutrient broth in a sterile flask and was sha-
ken to mix well. A 10-fold serial dilution was prepared 
with sodium chloride 0.85% (w/v) solution (from 10-1 
till 10-10) and 100 μL of culture. Then 100 μL from each 
dilution were used for direct cell count using Breed’s 
method (a laboratory technique for counting the living 
and dead bacteria [total number of bacteria] with methy-
lene blue staining) and colony count using the colony 
counting (a technique for counting the number of colo-
ny forming units of bacterial suspension). The flask was 
incubated 24 h in a shaker at 37 °C, and total cell count 
and CFU were determined at 1, 4, 8, 12, 16, 20, and 24 h 
after the incubation. Time-kill curves showed microbial 
growth depending on both time and EO concentration 
and it has been recommended to evaluate interaction 
between bacteria and anti-bacterial agent (30). The kil-
ling curves are described as the log10 CFU/mL versus 
time, up to 24 h (31).
X. strumarium EO effects on growth of E. coli 
O157:H7 in a batch culture
The inhibiting or killing effect of X. strumarium EO 
against E. coli O157:H7 was evaluated by measuring 
the reduction in the CFU/mL at different time of bacte-
ria growth using time- kill assay. Briefly, six concentra-
tions (5, 10, 15, 30, 60, and 120 mg/mL) of X. struma­
rium EO were used to evaluate its anti E. coli O157:H7 
activity. Then nutrient broth, bacterial culture and X. 
strumarium EO were added, mixed, and incubated in a 
shaker at 37 °C for a period ranging from 5 minute to 24 
h. Colonies formed on the nutrient agar and, then, CFU 
at different time points were counted. Killing curves 
were represented by plotting the log10 CFU/mL versus 
time up to 24 h. All assays were performed in triplicate 
and repeated for at least thrice (31-33).
X. strumarium EO effects on E. coli O157:H7 at dif-
ferent growth phases
Basing on results from the previous screening with 
agar diffusion test, two concentrations (15 and 30 mg/
mL) of X. strumarium EO were selected to evaluate the 
effect of them on E. coli O157:H7 at different growth 
phases (i.e. exponential, late exponential and stationary 
phase), in a batch culture. Three sets of experiments 
were performed to verify antibacterial effects during the 
different growth phase of bacteria. In each experiment, 
three flasks of each selected concentration (15 and 30 
mg/mL) were used. In all of them, at first, nutrient broth 
and bacterial suspension were mixed in a flask and 
the initial total number of viable cells and CFUs were 
determined using Breed’s method and colony counting 
method, respectively. Then, plant EO was added imme-
diately to the desired final concentration of 15 and 30 
mg/mL and let in incubation. Total and viable counts 
were determined at regular time points, after the expo-
sure to EO. 
X. strumarium EO effects on E. coli O157:H7 at expo-
nential phase
In the first experiment, the total count and viable 
count were determined at 2 and 4 h. Then plant EO was 
added immediately to a desired final concentration of 15 
71
Xanthium strumarium EO against shiga toxin-producing Escherichia coli.J. Sharifi-Rad et al. 2016 | Volume 62 | Issue 9
than the positive control. Based on this result 15 mg/mL 
and 30 mg/mL were selected for the future study.
X. strumarium EO effects on E. coli O157:H7 at dif-
ferent growth phases
Our results showed that X. strumarium L. EO at 30 
and 30 mg/mL. Total count and viable count were then 
determined at 4, 8, 12, 16, 20 and 24 h. 
X. strumarium EO effects on E. coli O157:H7 at late 
exponential phase
In the second experiment, total count and viable 
count were determined at 4, 6, and 8 h. Then plant EO 
was added immediately to a desired final concentration 
of 15 and 30 mg/mL. Total count and viable count were 
then determined at 10, 12, 16, 20 and 24 h.
X. strumarium EO effects on E. coli O157:H7 at sta-
tionary phase
In the third experiment, total count and viable count 
were determined at 16 h. Then plant EO was added im-
mediately to a desired final concentration of 15 and 30 
mg/mL. Total count and viable count were then determi-
ned at 16, 20, and 24 h. 
The bacterial growth reduction assessment was de-
termined by comparing viable cell counts (log10 CFU/
mL) between the control and treatments at specific time 
and to the initial inoculums. 
Bactericidal activity was defined as a reduction of 
99.9% (≥ 3 log10) of the CFU/mL in the original inocu-
lums. Bacteriostatic activity was defined as maintenance 
of the original inoculums concentration or a reduction 
of less than 99.9% (< 3 log10) of the CFU/mL in the 
original inoculums. We used from two controls (A nega-
tive control = (Plant EO + Nutrient broth without the 
bacterial) (Positive control = Nutrient broth containing 
bacterial suspension) to ensure from our results validity 
and to rule out any broth contamination (34).
Statistical analysis
Statistical analysis was performed using the Statis-
tical Package for Social Sciences (SPSS version 11.5, 
SPSS Inc., Chicago, IL). Statistical significance was 
determined by Chi square test. Statistical significance 
was set at p< 0.05.
Results
Antibacterial activity
The agar diffusion assay was used to assess antibac-
terial activity of the X. strumarium EO against E. coli 
O157:H7. At the concentration of 20 μL of X. struma­
rium EO /disc, the diameter of bacterial inhibition zone 
was 25.5 ± 0.2 mm, near to the chloramphenicol inhibi-
tion zone at 30 μg/disc (26.8 ± 0.1 mm). 
E. coli O157:H7 standard growth curve
The pathogen grew logarithmically following a 
sigmoidal curve as shown in Fig. 1. The four growth 
phases were defined, i.e. lag phase (0-1 h), exponential 
phase (1-4 h), late exponential phase (4-8 h) and statio-
nary phase (8-20 h).
X. strumarium EO effects on E. coli O157:H7 in a 
batch culture
The EO concentrations at 30, 60, and 120 mg/mL 
completely killed all bacteria in one hour of exposure: 
no bacterial colony could be detected. At lower concen-
trations (5 and 10, mg/mL) of EO and longer incubation 
some colonies were observed, though in lesser extent 
Figure 1. Standard growth profile of  E. coli O157:H7 in batch 
culture. Values are expressed as mean ± SD.
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Control * +++++
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Control +++++
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1 -
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24 -
Control +++++
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Control +++++
Table 1. Effects of Xanthium strumarium L. essential oil on the 
growth of E. coli O157:H7. (+: Bacterial growth,- : No growth).
72
Xanthium strumarium EO against shiga toxin-producing Escherichia coli.J. Sharifi-Rad et al. 2016 | Volume 62 | Issue 9
 
0
2
4
6
8
10
12
14
16
18
20
0 1 4 8 12 16 20 24
L
og
10
 /m
L
Time (h)
CFU count Total count
CFU count Total count
 
0
2
4
6
8
10
12
14
16
18
20
0 1 4 8 12 16 20 24
L
og
10
 /m
L
Time (h)
CFU count Total count
CFU count Total count
 
0
2
4
6
8
10
12
14
16
18
20
0 1 4 8 12 16 20 24
L
og
10
 /m
L
Time (h)
CFU count Total count
CFU count Total count
mg/mL killed all bacteria after 1 h, while at 15 mg/mL 
only decreased the number of bacteria. Therefore, for 
assessment of EO effectiveness on bacterial growth at 
different phases in a batch culture, both of these concen-
trations of EO were used.
X. strumarium EO effects on E. coli O157:H7 at expo-
nential phase
By adding 15 mg/mL of the X. strumarium EO to an 
exponential phase culture of the bacteria (after 2 h), the 
total cell counts and CFU decreased rapidly. A signifi-
cant difference (P < 0.05) was found between the EO 
treatment and control. In the treated culture CFU began 
to decrease to zero in 8 h then increased to 1011 within 
24 h (Fig. 2A). Total count also began to decrease in 1 h 
till 103 at 8 h; after that, it increased up to 1012 until the 
end of the incubation period, at 24 h.
By adding 30 mg/mL of the X. strumarium EO, 
CFU decreased to zero in 4 h then increased to 108 in 
24 h (Fig. 3A). Overall, the final CFU in EO treated 
cultures at 30 mg/mL concentration was 3-log lower 
than in cultures treated with EO at 15 mg/mL. Total 
count began to decrease within 1 h till 104 at 4 h; then, 
it increased from 104 in 4 h to 109 until the end of the 
incubation period, at 24 h.
X. strumarium EO effects on E. coli O157:H7 at late 
exponential phase
The EO at 15 mg/mL concentration was added 
during the late exponential phase of bacterial culture. 
The CFU and total count decreased rapidly to 105 in 8 
h and 103 in 12 h and remained unchanged until the end 
of the incubation period at 24 h (Fig. 2B). Total count 
decreased rapidly until 106 in 8 h and 105 in 12 h, then 
kept on decreasing slowly up to 104 in 16 h. It remained 
unchanged until the end of the incubation period, at 24 
h.  After the addition of 30 mg/mL of the EO, both num-
ber of cells and CFU decreased. CFU was zero within 
8 h and remained unchanged until the end of the incu-
bation period, at 24 h (Fig. 3B). Total count decreased 
from 108 in 1-4 h to 103 in 8h, keeping on decreasing 
till 101 in 12 h and, finally, zero in 20 h.  It remained 
unchanged until the end of the incubation period at 24 
Figure 2. Effects of 15 mg/mL Xantium  strumarium L. essential 
oil on E. coli O157:H7 growth at exponential phase (A), late expo-
nential phase (B), and stationary phase (C). Data are presented as 
the mean ± SD. Values are significantly different (P < 0.05).
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Figure 3. Effects of 30 mg/mL Xanthium strumarium L. essential 
oil on E. coli O157:H7 growth at exponential phase (A), late expo-
nential phase (B), and stationary phase(C). Data are presented as 
the mean ± SD. Values are significantly different (P < 0.05). (n=3).
A
C
B
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h. A significant difference (P <0.05) was found between 
the EO treatment and control.
X. strumarium EO effects on E. coli O157:H7 at sta-
tionary phase
The EO at 15 mg/mL concentration was added to 
the bacteria culture, at which time culture was in the 
stationary phase. Results showed that CFU and total 
count dropped rapidly. CFU decreased from 105 at base-
line to 1011 in 12h, and 102 in 16 h, to further decrease 
slowly until the end of the incubation period, at 24 h. 
In addition, total count decreased from 105 at baseline 
to 1012 in 12 h.  After EO addition it was 103 in 16 h, to 
decrease slowly until the end of the incubation period at 
24 h (Fig. 2C). Meanwhile both total counts and CFU 
were decreased. CFU increased from 105 to 1011 in 12 
h, then decreased nearly to zero in 16h and then slowly 
to zero until the end of the incubation period at 24 h. 
Total counts increased from 105 to 1012 in 12 h, then 
decreased nearly to zero in 16h and then slowly to zero 
until the end of the incubation period at 24 h (Fig. 3C). 
A significant difference (P < 0.05) was found between 
the treatments and controls.
Discussion
Our study showed that X. strumarium EO at 30, 60, 
and 120 mg/mL completely killed the organism in one 
hour of exposure. No bacterial colony was formed from 
1 h up to 24 h, after the exposure, suggesting bacteri-
cidal effect of the compound. At lower concentration 
the number of bacteria was decreased and some colo-
nies were observed after longer incubation, suggesting 
bacteriostatic effect of the compounds at this concen-
tration. Results of our study showed that the EO of X. 
strumarium at both concentrations (15 and 30 mg/mL) 
could not completely kill the cells at the exponential 
phase, and with longer incubation, until the end of the 
incubation period at 24 h, resistant cells could prolife-
rate. At 30 mg/mL EO could completely kill cells at the 
late exponential and stationary phases. Therefore, data 
confirmed the EO at 15 mg/mL was bacteriostatic, while 
at 30 mg/mL was bactericidal against E. coli O157:H7.
Yakob (27) studied the effect of Ocimum basilicum 
EO against anti-shiga toxin producing E. coli O157:h7. 
Our data are consistent with those on O. basilicum EO: 
Yakob showed that the latter could completely kill cells 
at the late exponential and stationary phases. McKay and 
Portnoy (35) also demonstrated that stationary-phase of 
bacteria is adequate phase for response to aminoglyco-
sides. Dhanya et al. (36) in a study on nimbolide from 
Azadirachta indica and its derivatives plus first-genera-
tion cephalosporin antibiotics described that significant 
reduction in the number of CFUs in the time kill assay 
was between 4 and 12 h. Also, in a study on the resis-
tance of planktonic and biofilm cultures of Burkholde­
ria cepacia to ciprofloxacin and ceftazidime, Authors 
showed that during the exponential phase of bacterial 
growth up to the stationary phase, the resistance of bac-
teria decreased and antibacterial effect of these drugs 
increased. This may be due to availability and consump-
tion rate of nutrient and oxygen and density of bacte-
ria population (37). Flandrois et al., (38) research on 
early stages of in vitro killing curve of LY 146032 and 
vancomycin for Staphylococcus aureus demonstrated 
a decrease of the bacterial population from 105 to 104 
CFU within 8 h with vancomycin. This is approxima-
tely the same as observed in previous studies on S. au­
reus. In their study, the killing of bacteria by LY146032 
increased from early stages of the bacterial growth up 
to the older phases. In addition, killing of bacteria was 
faster at the higher concentrations (34). 
Nonetheless, the time killing curves of Burt and 
Reinders (29) in a study on antibacterial activity of se-
lected plant EOs against E. coli O157:H7 were similar 
to ours.
Our study showed that the X. strumarium EO at 15 
mg/mL was only bacteriostatic, while at 30 mg/mL was 
bactericidal. The activity of the fraction is dependent on 
plant EO concentration and physiological state of the 
organism. It has been observed the best inhibition effect 
in late exponential phase and stationary phase during 
the growth curve of bacteria. Therefore, the antibacte-
rial properties of the EO were more effective towards 
the older culture of E. coli O157:H7, which are in active 
dividing phase. Finally, the X. strumarium EO was ef-
fective against anti-shiga toxin of E. coli O157:H7 and 
it could be further explored as natural antibacterial drug.
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